CoChat

In Vivo Insulin Sensitivity and Secretion in Obese Youth

Open access

The DOI matches its Crossref record, with a small difference in title or year; 27 of the 27 references it cites were found in a registry or an index.

Abstract

OBJECTIVE—Impaired glucose tolerance (IGT) represents a pre-diabetic state. Controversy continues in regards to its pathophysiology. The aim of this study was to investigate the differences in insulin sensitivity (IS) and secretion in obese adolescents with IGT compared with those with normal glucose tolerance (NGT) and type 2 diabetes. RESEARCH DESIGN AND METHODS—A total of 12 obese adolescents with NGT, 19 with IGT, and 17 with type 2 diabetes underwent evaluation of insulin sensitivity (3-h hyperinsulinemic [80mu/m2/min]–euglycemic clamp), first-phase insulin and second-phase insulin secretion (2-h hyperglycemic clamp), body composition, and abdominal adiposity. Glucose disposition index (GDI) was calculated as the product of first-phase insulin × insulin sensitivity. RESULTS—Insulin-stimulated glucose disposal was significantly lower in subjects with type 2 diabetes compared with subjects with NGT and IGT, with no difference between the latter two. However, compared with youth with NGT, youth with IGT have significantly lower first-phase insulin and C-peptide levels and GDI (P = 0.012), whereas youth with type 2 diabetes have an additional defect in second-phase insulin. Fasting and 2-h glucose correlated with GDI (r = −0.68, P < 0.001 and r = −0.73, P < 0.001, respectively) and first-phase insulin but not with insulin sensitivity. CONCLUSIONS—Compared with youth with NGT, obese adolescents with IGT have evidence of a β-cell defect manifested in impaired first-phase insulin secretion, with a more profound defect in type 2 diabetes involving both first- and second-phase insulin. GDI shows a significantly declining pattern: it is highest in NGT, intermediate in IGT, and lowest in type 2 diabetes. Such data suggest that measures to prevent progression or conversion from pre-diabetes to type 2 diabetes should target improvement in β-cell function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc08-1030

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 A: Insulin-stimulated total, oxidative, and nonoxidative glucose disposal in NGT (□), IGT (), and type 2 diabetes (▪). B: First and second-phase insulin levels in NGT (▵), IGT (), and type 2 diabetes (•). C: Glucose disposition index in NGT, IGT, and type 2 diabetes. Error bars reflect SEs.
Figure 1 A: Insulin-stimulated total, oxidative, and nonoxidative glucose disposal in NGT (□), IGT (), and type 2 diabetes (▪). B: First and second-phase insulin levels in NGT (▵), IGT (), and type 2 diabetes (•). C: Glucose disposition index in NGT, IGT, and type 2 diabetes. Error bars reflect SEs.CC BY-NC-ND · PubMed Central
Figure 2 Relation of first-phase insulin and GDI to the 2-h glucose during the OGTT in NGT (▵), IGT (), and type 2 diabetes (•).
Figure 2 Relation of first-phase insulin and GDI to the 2-h glucose during the OGTT in NGT (▵), IGT (), and type 2 diabetes (•).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Invitti C, Gilardini L, Viberti G: Impaired glucose tolerance in obese children and adolescents. N Engl J Med 347:290–292, 2002 · DOI

Cited by

See all 90

Metadata

Authors
Bacha, F., Gungor, N., Lee, S., & Arslanian, S. A.
Affiliations
  • Children's Hospital of Pittsburgh (US)
  • Anadolu Saglik Merkezi Gebze, Kocaeli, Turkey
Corresponding author
Bacha, Fida
Venue
Diabetes Care
Published
2009-01-01
Volume
32
Issue
1
Pages
100-105
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2160471613
Cited by
90
References
25
Citations by year
2026: 1 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 6 · 2019: 4 · 2018: 3 · 2017: 7 · 2016: 6 · 2015: 2 · 2014: 7 · 2013: 4 · 2012: 11
FWCI
7.38
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Diabetes Care (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • Pittsburgh Foundation
  • Thrasher Research Fund
  • U.S. Public Health Service (K24 HD01357, UL1 RR024153)
  • National Center for Research Resources (MO-1-RR-00084, UL1RR024153, M01RR000084)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01‐HD27503, R01HD027503, K24HD001357, K24 HD 01357)
  • Children's Hospital of Pittsburgh
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
insulin sensitivity, insulin secretion, impaired glucose tolerance, type 2 diabetes, adolescent obesity, beta-cell dysfunction, first-phase insulin secretion, second-phase insulin secretion, prediabetes, hyperinsulinemic-euglycemic clamp, hyperglycemic clamp, C-peptide, body composition, abdominal fat
MeSH terms
Abdomen, Insulin Secretion, Adipose Tissue, Adolescent, C-Peptide, Diabetes Mellitus, Type 2, Estradiol, Female, Glucose, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Insulin, Male, Obesity, Reference Values, Viscera, Glucose Clamp Technique, Body Mass Index, Glucose Intolerance, Dehydroepiandrosterone Sulfate, Black People, White People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.